Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation
暂无分享,去创建一个
B. Beuthien-Baumann | G. Ehninger | U. Platzbecker | M. Bornhäuser | I. Platzek | J. Middeke | R. Ordemann | F. Kroschinsky | J. Stöhlmacher | C. Zietz | J. Hoff